The global pediatric market essentially comprises of the healthcare services provided across various areas of healthcare industry. Children are often prone to illness and diseases and catch infections easily. Hence the pediatric market in terms of healthcare is a flourishing one, no matter what. Changes in lifestyle and unhealthy habits prevailing in the family largely contribute to the growth of this market.

The global market for pediatric interventional cardiology in 2014 is largely dominated by the Americas, especially in the U.S due to the increasing instances of cardiac diseases among the children. APAC region is poised to exhibit highest growth rate during the forecast period due to the flooding investments in pediatrics by major healthcare players in this region, especially from China and India. The improved healthcare services and governmental healthcare reforms and increased awareness among people drive the market for pediatric interventional cardiology in the APAC region.

The Global Pediatric Primary Care market is valued at 119700 million US$ in 2017 and will reach 159600 million US$ by the end of 2025, growing at a CAGR of 3.7% during 2018-2025.

According to the report, the global pediatric healthcare market was approximately USD 11,881 million in 2018 and is expected to generate around USD 15,984 million by 2025, at a CAGR of around 4.35% between 2019 and 2025.

Europe held the second spot in the global pediatric healthcare market in 2018, due to the increasing demand for chronic disease treatment, rising healthcare infrastructure, and growing enterprises of medical hospitals and clinics. Germany, the UK, and France are major countries in the European pediatric healthcare market. The UK is estimated to be growing rapidly over the forecast timeframe. Germany dominated the European market with a major revenue share in 2018, due to the increasing adoption of advanced medical treatment and various technological advancements.

It will focus on the latest and exciting innovations in all areas of Pediatric and Neonatology research which offers a unique opportunity for investigators across the globe to meet, network, and perceive new scientific innovations. This year’s Pediatric conference highlights the theme, “To Improve Health of the Child with Growing Research and Technology” which reflects the ground-breaking progress in Pediatric and Neonatology research. The two days conference includes Pediatric and neonatal care workshops, symposiums and special keynote sessions conducted by eminent and renowned speakers who excel in the field of Pediatrics and neonatology which include the topics Clinical Pediatrics, Pediatric Neurology, Pediatric emergency medicine, Pediatric oncology, neonatal nutrition, birth complications, neonatal infections, Pediatric and neonatal surgery. This global Pediatric conference also encourages the active participation of young students, upcoming researchers and budding scientists as we are hosting Neonatology Poster Award Competition and Young research Forum at the conference venue.

Pediatrics is the branch of medicine dealing with the care of infants, children and adolescents and the prevention and treatment of their diseases. Although most thinking and analysis of health care is taken from the adult health care system, issues surrounding pediatrics are unique and challenging and should be treated differently than adults.

A major challenge the Pediatric healthcare community faces is in relation to Medicaid funding. While the cost of health care for most children is relatively low, those who require hospitalization or specialty care experience a tremendous increase in total cost. Additionally, with a focus on preventative medicine, more resources need to be allocated to pediatrics. Medicaid funding for children estimates about 20 percent of total funds, yet children make up about 60 percent of enrollees. Typically, nursing homes and geriatrics utilize the most Medicaid dollars but for a much smaller population. While healthcare reform is an ongoing issue, the unique needs of children need to be included.

As per WHO, 5.4 million children under the age of five died in 2017 out of which infant mortality accounted for 75% (4.1 million). While UNICEF agrees with the data, its reports highlight that newborn mortality is not decreasing as quickly as that for children 1 to 59 months. Some of the major causes of mortality rate are preterm birth complications, acute respiratory infections, and intrapartum-related complications. Pediatrics is the branch of medical science dealing with the care for infants, children, and adolescents and its market is propelling due to cumulative cases of deaths, obesity, and infectious diseases such as measles, diphtheria, pneumonia, and poliomyelitis in children.

Leading Health Care Services of Pediatric Market

​

In the IndustryARC’s research report, the pediatric market is segmented under services into interventional cardiology, imaging, monitoring and diagnostics. The United States dominates the pediatric interventional cardiology market owing to increasing cases of cardiac diseases among children. A study from the Centers for Disease Control and Prevention (CDC) estimated that there were nearly 900,000 children in the U.S with different types of heart conditions. Owing to such gigantic figures, interventional cardiology segment is forecast to stroke the pediatric market with abundant demand.

In terms of products, antibiotic drugs segment is leading the pediatric medical care market due to their extensive application and effectiveness in treating bacterial infections. As per a chart formulated by PubMed- a database maintained by The United States National Library of Medicine (NLM) at the National Institutes of Health, nearly 16% of febrile patients in the pediatric emergency department were diagnosed with a serious bacterial infection. Due to such percentage detection, antibiotics are poised with the potential to lead the market towards exponential growth.

Globally, guardians are extra cognizant about the health of their children. Subsequently, the pediatrics market is evolving at an enormous stride with companies penetrating to get a critical share of the domain. The phenomenon can be rightly justified of its importance with the fact that European Union has determined the Pediatric market as an integral part of the overall development of the drugs industry.